Lumos Diagnostics Email Format
Biotechnology ResearchCalifornia, United States51-200 Employees
Lumos Diagnostics is a mid-sized biotechnology company focused on point-of-care diagnostic technology that aims to deliver rapid, affordable testing in clinical settings. It provides customized assay development and manufacturing services for POC tests and also develops proprietary digital reader platforms to support result interpretation. In addition, the firm develops, manufactures and commercializes Lumos-branded POC tests that address infectious and inflammatory diseases. The company operates from Carlsbad, California, and is listed on the Australian Securities Exchange as LDX. Its offerings are directed at healthcare professionals seeking faster, more accessible tools to inform diagnosis and treatment decisions at the point of care. Within the biotechnology research sector, Lumos combines development, manufacturing and commercialization capabilities for POC diagnostics. In April 2026, Lumos announced a new client, Micro-Pak Ltd, and secured a contract manufacturing agreement with a first purchase order.